CD38 and Miyoshi myopathy: Drent et al. demonstrated that CD38-specific CAR T-cells with a reduced affinity could effectively lyse MM cells with a high CD38 expression but spare CD38 low healthy hematopoietic cells in vitro and in vivo [94].